We developed a new combination scoring system involving CEA, CA 19-9, and CA 72-4, which we named the CTM (combination of preoperative tumor markers) score, and validated the score with a retrospective study to determine whether the CTM score was an independent prognostic factor for GC. This evidence concerns the gene CEACAM5 and neoplasm.